Article Versions Notes

Szymansky A, Kruetzfeldt L-M, Heukamp LC, Hertwig F, Theissen J, Deubzer HE, Willing E-M, Menon R, Fuchs S, Thole T, et al. Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing. Journal of Personalized Medicine. 2021; 11(8):691. https://doi.org/10.3390/jpm11080691

Szymansky, Annabell, Louisa-Marie Kruetzfeldt, Lukas C. Heukamp, Falk Hertwig, Jessica Theissen, Hedwig E. Deubzer, Eva-Maria Willing, Roopika Menon, Steffen Fuchs, Theresa Thole, and et al. 2021. "Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing" Journal of Personalized Medicine 11, no. 8: 691. https://doi.org/10.3390/jpm11080691

Szymansky, A., Kruetzfeldt, L.-M., Heukamp, L. C., Hertwig, F., Theissen, J., Deubzer, H. E., Willing, E.-M., Menon, R., Fuchs, S., Thole, T., Schulte, S., Schmelz, K., Künkele, A., Lang, P., Fuchs, J., Eggert, A., Eckert, C., Fischer, M., Henssen, A. G., ... Schulte, J. H. (2021). Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing. Journal of Personalized Medicine, 11(8), 691. https://doi.org/10.3390/jpm11080691